Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novavax Inc. sell tbackenh

Start price
€7.21
19.08.19 / 50%
Target price
€6.00
19.12.19
Performance (%)
-50.64%
End price
€3.56
19.12.19
Summary
This prediction ended on 19.12.19 with a price of €3.56. tbackenh correctly predicted massive losses of -50.64% for Novavax Inc.. tbackenh has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Novavax Inc. -9.013% -9.013% -56.805% -98.070%
iShares Core DAX® -1.670% -1.001% 10.864% 12.563%
iShares Nasdaq 100 -4.184% -1.145% 37.458% 41.078%
iShares Nikkei 225® -4.967% -5.783% 18.828% 0.655%
iShares S&P 500 -2.834% -0.572% 25.875% 39.960%

According to tbackenh what are the pros and cons of Novavax Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Innovative
Future proof or reliable business model
Cons
Risky balance sheet
High valuation
Higher risks for its business

Comments by tbackenh for this prediction

In the thread Novavax Inc. diskutieren
Prediction Sell
Perf. (%) -50.64%
Target price 6.000
Change
Ends at 19.12.19

Sell mit Kursziel 6,0

Prediction Sell
Perf. (%) -50.64%
Target price 6.000
Change
Ends at 19.12.19

Sell beendet